0001171843-26-005556 | 10-Q | XBRL Viewer

Technology Equipment [Member] | Maximum [Member]

5 years

Office Equipment [Member] | Minimum [Member]

7 years

Office Equipment [Member] | Maximum [Member]

3 years

Leasehold Improvements [Member] | Minimum [Member]

10 years

Leasehold Improvements [Member] | Maximum [Member]

1 year

^[1]

Laboratory Equipment [Member] | Minimum [Member]

2 years

^[1]

Laboratory Equipment [Member] | Maximum [Member]

4 years

10 years

[1]	Leasehold improvements are amortized over the shorter of the useful life or the remaining lease term.

Note 3 - Discontinued Operations - Schedule of Disposal Groups by Balance Sheet Classification (Details) - Discontinued Operations, Disposed of by Sale [Member] - Birmingham Laboratory and Eagan Business [Member]	Jun. 30, 2025 USD ($)
Accounts receivable, net	$ 37,297
Prepaid expense and other assets	10,426
Total current assets of discontinued operations	47,723
Other long-term assets	4,031
Total assets of discontinued operations	51,754
Accounts payable	1,149
Accrued expenses and other liabilities	252,015
Lease liability	89,040
Total current liabilities of discontinued operations	342,204
Total liabilities	$ 342,204

Note 13 - Net Loss Per Share - Schedule of Antidilutive Securities (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities (in shares) (in shares)	1,027,918	42,113	1,027,918	42,113
Warrant [Member]
Antidilutive Securities (in shares) (in shares)	1,617,043	940,412	1,617,043	940,412
Restricted Stock Units (RSUs) [Member]
Antidilutive Securities (in shares) (in shares)	0	0	0	0
Series B Convertible Preferred Stock [Member]
Antidilutive Securities (in shares) (in shares)	2	2	2	2

Note 4 - Revenue Recognition and Contracts with Customers 2 (Details)	Jun. 30, 2026 USD ($)
Revenue, Remaining Performance Obligation	$ 60,754,672
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-07-01
Revenue, Remaining Performance Obligation	29,301,246
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01
Revenue, Remaining Performance Obligation	7,053,109
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-01-01
Revenue, Remaining Performance Obligation	1,906,741
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2029-01-01
Revenue, Remaining Performance Obligation	$ 22,493,576

Note 12 - Stock-Based Compensation - Schedule of Share-based Compensation (Details) - USD ($)	3 Months Ended	6 Months Ended		12 Months Ended
	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025	Dec. 31, 2025
Outstanding, shares (in shares)		2,925
Outstanding, average exercise price (in dollars per share)		$ 1,334.98
Outstanding, Weighted-Average Remaining Contractual Term (Year)		9 years 7 months 24 days		2 years 11 months 26 days
Outstanding, Aggregate Intrinsic value		$ 5,372,100		$ 0
Issued, shares (in shares)	1,025,000	1,025,000	0
Issued, average exercise price (in dollars per share)		$ 1.09
Issued, Weighted-Average Remaining Contractual Term (Year)		9 years 8 months 1 day
Issued, Aggregate Intrinsic value		$ 5,372,100
Expired, shares (in shares)		(7)
Expired, average exercise price (in dollars per share)		$ 12,107.14
Expired, Aggregate Intrinsic value		$ 0
Exercised, shares (in shares)		0
Exercised, average exercise price (in dollars per share)		$ 0
Exercised, Aggregate Intrinsic value		$ 0
Outstanding, shares (in shares)		1,027,918		2,925
Outstanding, average exercise price (in dollars per share)		$ 6.05		$ 1,334.98

Note 9 - Leases

6 Months Ended

Jun. 30, 2026

Lessee, Operating Leases [Text Block]

NOTE 9 – LEASES

The Company’s corporate offices and other offices are located in Pittsburgh, Pennsylvania. The leases are effective through February 29, 2028.

Lease expense under operating lease arrangements, recorded within general and administrative expenses of continuing operations, was $196,169 for the three months ended June 30, 2026 and 2025, and $392,337and $392,503 for the six months ended June 30, 2026 and 2025, respectively.

The following table summarizes the operating lease asset and liabilities recorded as of June 30, 2026 and December 31, 2025:

	June 30, 2026			December 31, 2025
Operating lease right-of-use asset, gross	$	2,922,365		$	2,922,365
Accumulated amortization		(1,741,805	)		(1,434,662	)
Operating lease right-of-use asset, net		1,180,560			1,487,703

Short-term operating lease liabilities		708,159			653,743
Long-term operating lease liabilities		535,168			904,495
Total operating lease liabilities	$	1,243,327		$	1,558,238

Weighted average remaining lease term – operating leases in years		1.67			2.16
Weighted average discount rate – operating leases		12.5	%		13.0	%

The Company’s operating lease obligations as of June 30, 2026, which include expected lease extensions that are reasonably certain of renewal, were as follows:

2026 (remaining 6 months)	$	403,618
2027		827,909
2028		139,022
Total lease payments		1,370,549
Less: interest		(127,222	)
Present value of lease liabilities	$	1,243,327

Note 12 - Stock-Based Compensation (Details Textual) - USD ($) $ in Thousands			3 Months Ended		6 Months Ended
	Dec. 10, 2025	Sep. 09, 2025	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross				1,025,000	1,025,000	0
Share-Based Payment Arrangement, Expense			$ 600	$ 0	$ 700	$ 0
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)					3 years
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount			1,900		$ 1,900
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition					3 years
Share-Based Payment Arrangement, Option [Member] \| Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)					10 years
Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted (in shares)		60,101			33,330
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount			$ 0		$ 0
Restricted Stock Units (RSUs) [Member] \| Chief Executive Officer [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted (in shares)	20,000

Note 10 - Note Payable (Details Textual) - Insurance Policy Financing [Member] $ in Millions	Jun. 30, 2026 USD ($)	Jun. 30, 2025 USD ($)	Dec. 31, 2025 USD ($)
Debt Instrument, Face Amount	$ 0.4	$ 0.3
Debt Instrument, Number of Monthly Installment	10	10
Short-Term Debt, Percentage Bearing Fixed Interest Rate	6.10%	6.60%
Notes Payable	$ 0.4		$ 0.1

Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.

Note 2 - Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2026

Property Plant and Equipment Useful Life [Table Text Block]

	Years
Technology equipment	5	-	7
Computers, software, and office equipment	3	-	10
Leasehold improvements (1)	1	-	2
Laboratory equipment	4	-	10

Note 9 - Leases (Details Textual) - USD ($)	3 Months Ended	6 Months Ended
Note 9 - Leases (Details Textual) - USD ($)	Jun. 30, 2026	Jun. 30, 2025
Operating Lease, Expense	$ 196,169	$ 392,337

Note 4 - Revenue Recognition and Contracts with Customers - Contracts with Customers As Percentage of Total Revenue (Details) - Revenue from Contract with Customer Benchmark [Member] - Customer Concentration Risk [Member]	3 Months Ended	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2026
Customer A [Member]
Customer A	49.00%	49.00%
Customer B [Member]
Customer A	27.00%	27.00%

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

Note 5 - Digital Assets (Tables)

6 Months Ended

Jun. 30, 2026

Crypto Asset, Holding [Table Text Block]

	Units Held		Cost Basis		Fair Value
June 30, 2026		2,655,414,499	$	94,739,253	$	11,144,775
December 31, 2025		2,837,163,868	$	101,258,178	$	24,439,334

Crypto Asset, Activity [Table Text Block]

	For the Six Months Ended June 30, 2026
Fair Value, December 31, 2025	$	24,439,334

Purchases of ATH		-
ATH used in operations		(1,143,222	)
Interest income from ATH loaned		76,896
Realized (loss)		(1,329,854	)
Unrealized (loss)		(10,898,379	)
Fair Value, June 30, 2026	$	11,144,775

	For the Three Months Ended June 30, 2026
Fair Value, March 31, 2026	$	20,233,245

Purchases of ATH		-
ATH used in operations		(1,111,134	)
Interest income from ATH loaned		76,896
Realized (loss)		(1,329,854	)
Unrealized (loss)		(6,724,378	)
Fair Value, June 30, 2026	$	11,144,775

Note 15 - Subsequent Events (Details Textual) $ in Billions	Jul. 01, 2026 USD ($)
Subsequent Event [Member]
Contract Obligation, Contract Value	$ 2.8

Note 7 - Property and Equipment, Net (Tables)

6 Months Ended

Jun. 30, 2026

Property, Plant, and Equipment [Table Text Block]

	As of June 30, 2026			As of December 31, 2025
Computers, software, and office equipment	$	170,350		$	170,350
Construction in progress - Technology equipment		17,100,106			-
Leasehold improvements		166,847			166,847
Laboratory equipment		1,713,230			1,692,230
Total		19,150,533			2,029,427
Less: Accumulated depreciation		(1,858,660	)		(1,806,299	)
Total Property and equipment, net	$	17,291,873		$	223,128

Note 13 - Net Loss Per Share (Details Textual)	Jun. 30, 2026 shares
Prefunded Warrants [Member]
Class of Warrant or Right, Outstanding (in shares)	9,972,424

Note 8 - Commitments And Contingencies - Schedule of Commitments (Details) - Compute Agreements [Member]	Jun. 30, 2026 USD ($)
2026 (remaining 6 months)	$ 16,757,954
2027	107,744,100
2028	99,220,630
2029	38,852,831
Total	$ 262,575,515

Note 12 - Stock-Based Compensation - Schedule of Nonvested Restricted Stock Units Activity (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares	6 Months Ended
	Jun. 30, 2026	Dec. 31, 2025
Non-vested RSUs as of December 31, 2024, shares (in shares)	20,000
Non-vested RSUs as of December 31, 2024, average exercise price (in dollars per share)		$ 5.92
Granted, number of shares (in shares)	33,330
Granted, average exercise price (in dollars per share)	$ 5.84
Vested, number of shares (in shares)	(53,330)
Vested, weighted-average grant date fair value (in dollars per share)	$ 5.86
Non-vested RSUs as of September 30, 2025, shares (in shares)	0

Note 7 - Property and Equipment, Net - Schedule of Property, Plant and Equipment (Details) - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Property, Plant, and Equipment Gross	$ 19,150,533	$ 2,029,427
Less: Accumulated depreciation	(1,858,660)	(1,806,299)
Total Property and equipment, net	17,291,873	223,128
Office Equipment [Member]
Property, Plant, and Equipment Gross	170,350	170,350
Technology Equipment [Member]
Property, Plant, and Equipment Gross	17,100,106	0
Leasehold Improvements [Member]
Property, Plant, and Equipment Gross	166,847	166,847
Laboratory Equipment [Member]
Property, Plant, and Equipment Gross	$ 1,713,230	$ 1,692,230

Amount of accumulated depreciation, depletion, and amortization of property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection.

Amount, after accumulated depreciation, depletion, and amortization, of property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 360
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478443/942-360-45-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 360
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478451/942-360-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(8))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 842
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481372/852-10-55-10

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(8))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1

Note 11 - Stockholders' Equity (Details Textual) - USD ($) $ / shares in Units, $ in Millions		1 Months Ended	6 Months Ended		24 Months Ended
	Oct. 07, 2025	Apr. 30, 2026	Jun. 30, 2026	Jun. 30, 2025	May 13, 2026	May 15, 2026	Oct. 29, 2025	Sep. 30, 2025	Jun. 02, 2025	May 31, 2025	Apr. 18, 2025	May 03, 2024
Cash PIPE Warrants [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)	$ 0.01
Crypto PIPE Warrants [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)	$ 0.01
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)	14,903,393
Prefunded Warrant [Member]
Class of Warrant or Right, Exercised During Period (in shares)			6,146,671
Class of Warrant or Right, Outstanding (in shares)			9,972,424
Stock Warrants [Member]
Issued, shares (in shares)			0	0
Sales Agreement [Member]
Sale of Stock, Commissions, Percent												3.00%
Sale of Stock, Additional Amount											$ 1.5
Sale of Stock, Remaining Available Balance								$ 2.3		$ 1.4
Sale of Stock, Maximum Amount			$ 83.0			$ 100.0	$ 18.3		$ 3.4
Stock Issued During Period, Shares, New Issues (in shares)		1,063,864
Shares Issued, Price Per Share (in dollars per share)		$ 10.22
Net Proceeds from Issuance of Common Stock		$ 10.3
Stock Issued During Period, Value, New Issues					$ 17.0
Equity Offering, Remaining Capacity			$ 83.0
Equity Offering, Public Float Threshold						$ 75.0
Cash PIPE SPA [Member]
Stock Issued During Period, Shares, New Issues (in shares)	4,366,703
Shares Issued, Price Per Share (in dollars per share)	$ 11.6265

Note 15 - Subsequent Events

6 Months Ended

Jun. 30, 2026

Subsequent Events [Text Block]

NOTE 15 – SUBSEQUENT EVENTS

Significant Contracts

In July 2026, the Company secured three new customer contracts with a total contract value of more than $2.8 billion across the United States and Europe. The agreements, secured through the Axe Compute Build program, expand Axe Compute’s design-deploy-own-operate model into additional geographies and add significant dedicated, large-scale AI infrastructure capacity to its global footprint.

Note 12 - Stock-Based Compensation (Tables)

6 Months Ended

Jun. 30, 2026

Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]

	Number of Shares			Weighted-Average Grant Date Fair Value per RSU
Non-vested RSUs as of December 31, 2025		20,000		$	5.92
Granted		33,330		$	5.84
Vested		(53,330	)	$	5.86
Non-vested RSUs as of June 30, 2026		-

Share-Based Payment Arrangement, Activity [Table Text Block]

	Number of Shares			Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Term (Years)		Aggregate Intrinsic value
Outstanding as of December 31, 2025		2,925		$	1,334.98		2.99		-
Issued		1,025,000		$	1.09		9.67	$	5,372,100
Expired		(7	)	$	12,107.14		-		-
Exercised		-			-		-		-
Outstanding as of June 30, 2026		1,027,918		$	6.05		9.65	$	5,372,100

Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

	Six Months Ended June 30,
	2026			2025
Expected dividend yield		0.0	%		0.0	%
Expected stock price volatility		99.4% - 103.5	%		99.4	%
Risk-free interest rate		4.22% - 4.33	%		4.37	%
Expected life (in years)	10			5

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 21,905,767	$ 10,790,850
Accounts receivable	3,321,426	32,120
Compute prepayments	11,148,981	0
Other prepaid expense and current assets	873,423	280,904
Digital assets	11,268,342	24,439,598
Digital asset receivable	7,547,221	7,226,475
Total current assets	56,065,160	42,769,947
Compute prepayments, net of current portion	22,946,761
Digital asset receivable, net of current portion	2,745,004	8,258,681
Property and equipment, net	17,291,873	223,128
Lease right-of-use assets	1,180,560	1,487,703
Other long-term assets	146,598	148,887
Total assets	100,375,956	52,888,346
Current liabilities:
Accounts payable	2,494,038	1,840,608
Note payable	413,611	107,951
Accrued expenses and other liabilities	1,425,113	1,520,518
Contract liabilities	33,645,987	144,076
Lease liability	708,159	653,743
Total current liabilities	38,686,908	4,266,896
Contract liabilities, net of current portion	27,108,685	0
Lease liability, net of current portion	535,168	904,495
Total liabilities	66,330,761	5,171,391
Common stock, $.01 par value, 200,000,000 shares authorized, 11,384,940 and 4,083,173 shares outstanding as of June 30, 2026, and December 31, 2025, respectively	113,849	40,832
Additional paid-in capital	472,366,853	461,196,805
Accumulated deficit	(438,436,299)	(413,521,474)
Total stockholders’ equity	34,045,195	47,716,955
Total liabilities and stockholders’ equity	100,375,956	52,888,346
Series B Convertible Preferred Stock [Member]
Current liabilities:
Series B Convertible Preferred Stock, $.01 par value, 2,300,000 shares authorized, 79,246 shares outstanding as of June 30, 2026 and December 31, 2025	$ 792	$ 792

Note 13 - Net Loss Per Share - Schedule of Earnings Per Share (Details) - USD ($)

3 Months Ended

6 Months Ended

Jun. 30, 2026

Jun. 30, 2025

Jun. 30, 2026

Jun. 30, 2025

Net (loss) from continuing operations

$ (17,205,882)

$ (1,978,896)

$ (24,914,825)

$ (4,264,311)

Loss from discontinued operations

(91,567)

(249,024)

Net (loss) attributable to common stockholders

$ (17,205,882)

$ (2,070,462)

$ (24,914,825)

$ (4,513,335)

Weighted average common shares outstanding - basic (in shares)

19,685,811

9,108,984

17,167,696

8,136,008

Dilutive effect of stock options, warrants and preferred stock (in shares)

^[1]

Weighted average common shares outstanding - diluted (in shares)

19,685,811

9,108,984

17,167,696

8,136,008

Net (loss) from continuing operations attributable to common stockholders per common share – basic and diluted (in dollars per share)

$ (0.87)

$ (0.22)

$ (1.45)

$ (0.52)

Net (loss) from discontinued operations attributable to common stockholders per common share – basic and diluted (in dollars per share)

(0.01)

(0.03)

(Loss) per common share - basic and diluted (in dollars per share)

$ (0.87)

$ (0.23)

$ (1.45)

$ (0.55)

[1]	The following is a summary of the number of underlying shares outstanding at the end of the respective periods that have been excluded from the diluted calculations because the effect on loss per common share would have been anti-dilutive:

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482705/350-40-65-4

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479719/606-10-65-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 9
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-9

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 17
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480336/718-10-65-17

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 52
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482635/260-10-55-52

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482635/260-10-55-15

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-7

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-2

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-10

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-7

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

Amount after tax of income (loss) from continuing operations attributable to the parent.

The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482705/350-40-65-4

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479719/606-10-65-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 9
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-9

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(13))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-7

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

Reference 23: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(20))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.

Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.

Condensed Consolidated Statement of Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Series B Convertible Preferred Stock [Member] Preferred Stock [Member] May 2025 Private Placement [Member]	Series B Convertible Preferred Stock [Member] Preferred Stock [Member] At The Market Offering [Member]	Series B Convertible Preferred Stock [Member] Preferred Stock [Member]	Common Stock [Member] Registered Direct Offering [Member]	Common Stock [Member] Renovaro Extension Agreement [Member]	Common Stock [Member] May 2025 Private Placement [Member]	Common Stock [Member] At The Market Offering [Member]	Common Stock [Member]	Additional Paid-in Capital [Member] Registered Direct Offering [Member]	Additional Paid-in Capital [Member] Renovaro Extension Agreement [Member]	Additional Paid-in Capital [Member] May 2025 Private Placement [Member]	Additional Paid-in Capital [Member] At The Market Offering [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member] Registered Direct Offering [Member]	Retained Earnings [Member] Renovaro Extension Agreement [Member]	Retained Earnings [Member] May 2025 Private Placement [Member]	Retained Earnings [Member] At The Market Offering [Member]	Retained Earnings [Member]	Registered Direct Offering [Member]	Renovaro Extension Agreement [Member]	May 2025 Private Placement [Member]	At The Market Offering [Member]	Total
Balance (in shares) at Dec. 31, 2024			79,246					444,475
Balance at Dec. 31, 2024			$ 792					$ 4,445					$ 180,218,424					$ (180,426,271)					$ (202,610)
Issuance of shares pursuant to Warrant Inducement Transaction, net of issuance costs (in shares)								95,601
Issuance of shares pursuant to Warrant Inducement Transaction, net of issuance costs								$ 956					1,533,426					0					1,534,382
Net loss													0					(2,442,873)					(2,442,873)
Issuance of shares pursuant to At The Market Offering, net of issuance costs (in shares)				24,223	31,153
Issuance of shares pursuant to At The Market Offering, net of issuance costs				$ 242	$ 312				$ 465,063	$ 499,688				$ 0	$ 0				$ 465,305	$ 500,000
Net loss													0					(2,442,873)					(2,442,873)
Balance (in shares) at Mar. 31, 2025			79,246					595,452
Balance at Mar. 31, 2025			$ 792					$ 5,955					182,716,601					(182,869,144)					(145,796)
Balance (in shares) at Dec. 31, 2024			79,246					444,475
Balance at Dec. 31, 2024			$ 792					$ 4,445					180,218,424					(180,426,271)					(202,610)
Net loss																							(4,513,335)
Net loss																							(4,513,335)
Balance (in shares) at Jun. 30, 2025			79,246					639,798
Balance at Jun. 30, 2025			$ 792					$ 6,399					183,279,017					(184,939,606)					(1,653,398)
Balance (in shares) at Mar. 31, 2025			79,246					595,452
Balance at Mar. 31, 2025			$ 792					$ 5,955					182,716,601					(182,869,144)					(145,796)
Issuance of shares to non-employees (in shares)								6,667
Issuance of shares to non-employees								$ 67					99,933					0					100,000
Net loss																		(2,070,462)					(2,070,462)
Issuance of shares pursuant to At The Market Offering, net of issuance costs (in shares)	0					18,692	18,987
Issuance of shares pursuant to At The Market Offering, net of issuance costs	$ 0					$ 187	$ 190				$ 299,813	$ 162,670				$ 0	$ 0				$ 300,000	$ 162,860
Net loss																		(2,070,462)					(2,070,462)
Balance (in shares) at Jun. 30, 2025			79,246					639,798
Balance at Jun. 30, 2025			$ 792					$ 6,399					183,279,017					(184,939,606)					(1,653,398)
Balance (in shares) at Dec. 31, 2025			79,246					4,083,173
Balance at Dec. 31, 2025			$ 792					$ 40,832					461,196,805					(413,521,474)					47,716,955
Share-based compensation related to instruments granted to employees													111,358					0					111,358
Issuance of common stock, net, in connection with restricted stock units vesting (in shares)								13,242
Issuance of common stock, net, in connection with restricted stock units vesting								$ 132					(17,576)					0					(17,444)
Issuance of shares to non-employees (in shares)								23,613
Issuance of shares to non-employees								$ 237					168,597					0					168,833
Issuance of shares pursuant to Warrant Inducement Transaction, net of issuance costs (in shares)								1,419,239
Issuance of shares pursuant to Warrant Inducement Transaction, net of issuance costs								$ 14,193					(14,192)					0					1
Net loss													0					(7,708,943)					(7,708,943)
Net loss													0					(7,708,943)					(7,708,943)
Balance (in shares) at Mar. 31, 2026			79,246					5,539,267
Balance at Mar. 31, 2026			$ 792					$ 55,394					461,444,992					(421,230,417)					40,270,761
Balance (in shares) at Dec. 31, 2025			79,246					4,083,173
Balance at Dec. 31, 2025			$ 792					$ 40,832					461,196,805					(413,521,474)					47,716,955
Net loss																							(24,914,825)
Net loss																							(24,914,825)
Balance (in shares) at Jun. 30, 2026			79,246					11,384,940
Balance at Jun. 30, 2026			$ 792					$ 113,849					472,366,853					(438,436,299)					34,045,195
Balance (in shares) at Mar. 31, 2026			79,246					5,539,267
Balance at Mar. 31, 2026			$ 792					$ 55,394					461,444,992					(421,230,417)					40,270,761
Share-based compensation related to instruments granted to employees													571,584					0					571,584
Issuance of common stock, net, in connection with restricted stock units vesting (in shares)								26,393
Issuance of common stock, net, in connection with restricted stock units vesting								$ 264					(56,941)					0					(56,677)
Issuance of shares to non-employees (in shares)			0					27,984
Issuance of shares to non-employees			$ 0					$ 279					129,006					0					129,285
Issuance of shares pursuant to Warrant Inducement Transaction, net of issuance costs (in shares)			0					4,727,432
Issuance of shares pursuant to Warrant Inducement Transaction, net of issuance costs			$ 0					$ 47,274					(47,274)					0					0
Net loss								0					0					(17,205,882)					(17,205,882)
Issuance of shares pursuant to At The Market Offering, net of issuance costs (in shares)		0					1,063,864
Issuance of shares pursuant to At The Market Offering, net of issuance costs		$ 0					$ 10,638					$ 10,325,486					$ 0					$ 10,336,124
Net loss								$ 0					0					(17,205,882)					(17,205,882)
Balance (in shares) at Jun. 30, 2026			79,246					11,384,940
Balance at Jun. 30, 2026			$ 792					$ 113,849					$ 472,366,853					$ (438,436,299)					$ 34,045,195

Document And Entity Information - shares	6 Months Ended
Document And Entity Information - shares	Jun. 30, 2026	Aug. 13, 2026
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2026
Document Transition Report	false
Entity File Number	001-36790
Entity Registrant Name	Axe Compute Inc
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	33-1007393
Entity Address, Address Line One	91 43rd Street, Suite 110
Entity Address, City or Town	Pittsburgh
Entity Address, State or Province	PA
Entity Address, Postal Zip Code	15201
City Area Code	412
Local Phone Number	432-1500
Title of 12(b) Security	Common stock, $0.01 par value
Trading Symbol	AGPU
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		11,591,124
Entity Central Index Key	0001446159
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2026
Document Fiscal Period Focus	Q2
Amendment Flag	false

Note 8 - Commitments And Contingencies (Tables)

6 Months Ended

Jun. 30, 2026

Contractual Obligation, Fiscal Year Maturity [Table Text Block]

2026 (remaining 6 months)	$	16,757,954
2027		107,744,100
2028		99,220,630
2029		38,852,831
Total	$	262,575,515

Note 11 - Stockholders' Equity - Schedule of Warrants (Details) - Stock Warrants [Member]	6 Months Ended
	Jun. 30, 2026 $ / shares shares
Outstanding, shares (in shares)	1,623,179
Outstanding, average exercise price (in dollars per share) \| $ / shares	$ 17.39
Issued, shares (in shares)	0
Expired (in shares)	0
Exercised, shares (in shares)	(6,136)
Exercised, average exercise price (in dollars per share) \| $ / shares	$ 219.09
Outstanding, shares (in shares)	1,617,043
Outstanding, average exercise price (in dollars per share) \| $ / shares	$ 16.62

Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2026

Accounting Policies [Abstract]

Basis of Accounting, Policy [Policy Text Block]

Basis of Presentation and Principles of Consolidation

The Company has prepared the condensed consolidated financial statements and related unaudited financial information in the notes in accordance with GAAP and the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim condensed consolidated financial statements. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These interim condensed consolidated financial statements reflect all adjustments consisting of normal recurring adjustments, which in the opinion of management, are necessary to present fairly the Company’s position, the results of its operations, and its cash flows for the interim periods. These interim condensed consolidated financial statements reflect all intercompany eliminations. These interim condensed consolidated financial statements should be read in conjunction with the annual consolidated financial statements and the notes thereto contained in the Annual Report on Form 10-K filed with the SEC on March 31, 2026.

As of and for the six months ended June 30, 2026, and 2025, the Company had two wholly owned subsidiaries, Helomics Corporation and Skyline Medical Inc. (“Skyline Medical”). On March 14, 2025, the Company sold the Skyline Medical business pursuant to an asset purchase agreement with DeRoyal Industries, Inc.; however, Skyline Medical remained a wholly owned subsidiary of Axe Compute following the transaction, with its activities limited to wind-down efforts that were substantially completed as of December 31, 2025. The condensed consolidated financial statements include the accounts of the Company and these wholly owned subsidiaries, with all intercompany transactions and balances eliminated, as of and for the six months ended June 30, 2026 and 2025.

Discontinued Operations, Policy [Policy Text Block]

Discontinued Operations

In March 2025, the Company disposed of its former Eagan operating segment. Disposal groups that meet the discontinued operations criteria provided in ASC 205-20-45 are classified as discontinued operations. Assets and liabilities of discontinued operations are presented separately in the Company’s condensed consolidated balance sheets and results of discontinued operations are reported as a separate component of net loss in the Company’s condensed consolidated statements of net loss for all periods presented, resulting in changes to the presentation of certain prior period amounts. Results of discontinued operations are excluded from segment results for all periods presented. Cash flows from discontinued operations are also reported separately in the Company’s condensed consolidated statements of cash flows.

Refer to Note 3 – Discontinued Operations for additional discussion of discontinued operations. All other notes to these condensed consolidated financial statements present the results of continuing operations and exclude amounts related to discontinued operations for all periods presented.

Use of Estimates, Policy [Policy Text Block]

Accounting Policies and Use of Estimates

The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and during the reporting period. Actual results could materially differ from those estimates. Estimates are used in the following areas, among others: variable consideration associated with revenue recognition, stock-based compensation expense, fair value of derivatives including embedded derivatives, fair value of digital assets, fair value of long-lived assets for impairment analyses, the valuation allowance included in the deferred income tax calculation, accrued expenses, useful lives assigned to property and equipment, and determination of contract commencement dates. The Company bases its estimates on historical experience and assumptions that management considers reasonable. Assumptions are reviewed regularly to ensure they remain relevant and reasonable, particularly in areas of high subjectivity.

Note 2 to the annual consolidated financial statements contained in the Annual Report on Form 10-K filed with the SEC on March 31, 2026, describes the significant accounting policies and estimates used in preparation of the consolidated financial statements. There have been no material changes in the Company’s significant accounting policies during the six months ended June 30, 2026, with the exception of the items noted below.

Revenues from GPU Compute Services

Revenue from the Company’s GPU compute services segment is generated from subscription-based arrangements with enterprise, research, and commercial customers under master services agreements and related order forms. These arrangements provide customers with continuous access to specified GPU compute resources (including GPU type, quantity, and configuration) at designated data center locations over defined service periods, which may range from month-to-month to multi-year terms. Certain contracts also include ancillary storage services, which are accounted for as separate performance obligations when distinct.

The Company procures GPU compute capacity from third-party node operators and decentralized cloud infrastructure platforms and resells that capacity to its customers. The Company has concluded that it acts as a principal in these arrangements, as it controls the GPU compute services prior to transferring to the customer, including directing the use of, and obtaining substantially all benefits from, the underlying capacity. Additionally, the Company bears inventory risk and has full discretion regarding the pricing of contracts with customers. Accordingly, revenue is recognized on a gross basis.

GPU compute and related storage services are each considered a series of distinct services that are substantially the same and are satisfied over time, as customers simultaneously receive and consume the benefits of these services as they are provided. Revenue is recognized over time using an output method that faithfully depicts the Company’s performance. For fixed-fee arrangements, revenue is recognized on a straight-line basis over the applicable service period, as the customer receives a consistent level of benefit throughout the term. Usage-based fees, including overage charges based on GPU-hours consumed in excess of contractual limits, are recognized as revenue in the period in which the usage occurs.

The transaction price primarily consists of fixed monthly subscription fees, which are generally non-cancellable and non-refundable during the contract term. Arrangements might include usage-based overages; however, for the period ended June 30, 2026, any variable consideration was immaterial. Variable consideration is included in revenue only to the extent it is probable that a significant reversal will not occur. For contracts with multiple performance obligations, such as combined GPU compute and storage services, the transaction price is allocated to performance obligations based on relative standalone selling prices. The Company has concluded that these arrangements do not contain significant financing components.

Property, Plant, and Equipment [Policy Text Block]

Property and equipment

Property and equipment are stated at cost less accumulated depreciation. Construction-in-progress is related to the construction or development of property and equipment that has not yet been placed into service for its intended use. Depreciation of property and equipment is computed using the straight-line method over the estimated useful lives of the respective assets.

The estimated useful lives of the Company’s property and equipment are as follows:

	Years
Technology equipment	5	-	7
Computers, software, and office equipment	3	-	10
Leasehold improvements (1)	1	-	2
Laboratory equipment	4	-	10

(1)	Leasehold improvements are amortized over the shorter of the useful life or the remaining lease term.

Upon retirement or sale of property and equipment, the cost and related accumulated depreciation are removed from the consolidated balance sheet and the resulting gain or loss is recorded in operations. Expenditures for maintenance and repairs that do not extend the lives of the respective assets are expensed as incurred.

Compute Repayments [Policy Text Block]

Compute prepayments

The Company enters into agreements with third-party vendors to reserve and obtain GPU compute capacity, related storage, networking, and support services. Under these arrangements, the Company is generally required to make prepayments equal to either (1) a percentage of overall contract value or (2) a value equal to the monthly service payment for a number of months. In addition to these prepayments, the Company has monthly service payments over contract terms ranging from 12 to 36 months.

Upon transferring these prepayments, the Company records a compute prepayment as a prepaid asset. The prepaid balance is subsequently recognized as expense over the period in which the related services are received. For arrangements where the prepayment represents an advance payment for services evenly consumed over the contract term, the prepaid balance is amortized on a straight-line basis over the applicable service period. For arrangements where the prepayment relates to specific months of service, the prepaid balance is relieved and recognized as expense in the months to which the prepayment applies, consistent with the pattern of benefit received. Monthly service payments are recognized as expense as incurred in accordance with the underlying contractual terms. The Company evaluates compute prepayments each reporting period to determine whether the recorded balance remains recoverable and appropriately reflects expected future service consumption.

The timing of service deployment and commencement under certain compute capacity arrangements is dependent on a variety of third-party factors, including original equipment manufacturer (“OEM”) schedules, GPU allocation timing, logistics, and other operational dependencies. As a result, at the time a compute prepayment is made, the exact period over which the prepaid balance will be utilized may not be known with certainty. Management is therefore required to estimate the expected service commencement date and the period over which the related services will be received in order to determine the appropriate classification of compute prepayments between current and non-current assets and to establish the amortization period. These estimates are based on the facts and circumstances known at the reporting date and are reassessed each reporting period. Changes in actual deployment timing or service consumption patterns may result in adjustments to the classification and timing of expense recognition in future periods.

Risk and Uncertainties [Policy Text Block]

Risks and Uncertainties

Note 2 to the annual consolidated financial statements contained in the Annual Report on Form 10-K filed with the SEC on March 31, 2026, describes certain risks and uncertainties associated with the Company and relevant to the Company’s consolidated financial statements. There have been no additional risks and uncertainties identified by Management in the six months ended June 30, 2026.

New Accounting Pronouncements, Policy [Policy Text Block]

Recently Issued Accounting Pronouncements

The Company considers the applicability and impact of all Accounting Standards Updates (“ASUs”) issued by the Financial Accounting Standards Board (“FASB”). Recently issued ASUs not listed below either were assessed and determined to be not applicable or are currently expected to have no impact on the consolidated financial statements of the Company.

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. This ASU requires more detailed disclosures related to certain costs and expenses. The guidance requires entities to disclose amounts of certain expense categories included in expense captions presented on the face of the income statement, including purchases of inventory, employee compensation, depreciation, and intangible asset amortization. This ASU is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The disclosure requirements may be applied either prospectively or retrospectively. Management is currently evaluating this ASU to determine its impact on the Company’s disclosures.

Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-12

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-9

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482836/275-10-55-6

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-6

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-4

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-SubTopic 10
-Topic 275
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-SubTopic 10
-Topic 275
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-1

Note 4 - Revenue Recognition and Contracts with Customers (Details) (Parentheticals)	Jun. 30, 2026
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-07-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period (Year)	6 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period (Year)	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period (Year)	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2029-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period (Year)	1 year

Note 9 - Leases - Lease Information (Details) - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Operating lease right-of-use asset, gross	$ 2,922,365	$ 2,922,365
Accumulated amortization	(1,741,805)	(1,434,662)
Lease right-of-use assets	1,180,560	1,487,703
Lease liability	708,159	653,743
Lease liability, net of current portion	535,168	904,495
Total operating lease liabilities	$ 1,243,327	$ 1,558,238
Weighted average remaining lease term – operating leases in years (Year)	1 year 8 months 1 day	2 years 1 month 28 days
Weighted average discount rate – operating leases	12.50%	13.00%

Note 9 - Leases - Rent Obligation (Details) - USD ($)	Jun. 30, 2026	Dec. 31, 2025
2026 (remaining 9 months)	$ 403,618
2027	827,909
2028	139,022
Total lease payments	1,370,549
Less: interest	(127,222)
Present value of lease liabilities	$ 1,243,327	$ 1,558,238

Note 2 - Summary of Significant Accounting Policies (Details Textual) - Compute Agreements [Member]	3 Months Ended
	Jun. 30, 2026
Minimum [Member]
Contractual Obligation, Term (Month)	12 months
Maximum [Member]
Contractual Obligation, Term (Month)	36 months

Note 14 - Segment Information (Details Textual)	6 Months Ended
Note 14 - Segment Information (Details Textual)	Jun. 30, 2026
Number of Operating Segments	2
Number of Reportable Segments	2
Number of Tumor Samples	150,000

Note 11 - Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2026

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

	Number of Shares			Weighted-Average Exercise Price
Outstanding as of December 31, 2025		1,623,179		$	17.39
Issued		-
Expired		-
Exercised		(6,136	)		219.09
Outstanding as of June 30, 2026		1,617,043		$	16.62

Note 9 - Leases (Tables)

6 Months Ended

Jun. 30, 2026

Lease, Cost [Table Text Block]

	June 30, 2026			December 31, 2025
Operating lease right-of-use asset, gross	$	2,922,365		$	2,922,365
Accumulated amortization		(1,741,805	)		(1,434,662	)
Operating lease right-of-use asset, net		1,180,560			1,487,703

Short-term operating lease liabilities		708,159			653,743
Long-term operating lease liabilities		535,168			904,495
Total operating lease liabilities	$	1,243,327		$	1,558,238

Weighted average remaining lease term – operating leases in years		1.67			2.16
Weighted average discount rate – operating leases		12.5	%		13.0	%

Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]

2026 (remaining 6 months)	$	403,618
2027		827,909
2028		139,022
Total lease payments		1,370,549
Less: interest		(127,222	)
Present value of lease liabilities	$	1,243,327

Note 5 - Digital Assets - Reconciliation of Digital Assets (Details) - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2026
Fair Value	$ 11,144,775	$ 11,144,775
Aethir (ATH) [Member]
Fair Value	20,233,245	24,439,334
Deposits	0	0
ATH used in operations	(1,111,134)	(1,143,222)
Interest income from ATH loaned	76,896	76,896
Realized (loss)	(1,329,854)	(1,329,854)
Unrealized gain / (loss)	(6,724,378)	(10,898,379)
Fair Value	$ 11,144,775	$ 11,144,775

Note 14 - Segment Information

6 Months Ended

Jun. 30, 2026

Segment Reporting [Text Block]

NOTE 14 – SEGMENT INFORMATION

The Company has determined its operating segments in accordance with ASC 280, Segment Reporting. Factors used to determine the Company’s reportable segments include the availability of separate financial statements, the existence of separate leadership across business lines, the economic factors affecting each segment, and the evaluation of operating results at the segment level. The Company’s Chief Operating Decision Maker (“CODM”), its chief executive officer, allocates the Company’s resources for each of the operating segments and evaluates their relative performance based on losses from operations, operating loss, and net loss. Operating expenses are disaggregated by department for purposes of evaluating each segment’s performance. Each operating segment listed below has separate financial statements and locally based leadership that are evaluated based on the results of their respective segments. It should be noted that the operating segments below have different products and services.

The Company has two reportable segments, which have been delineated by business area:

●

Compute Services and Treasury Management segment: provides services that include access to GPU compute capacity and manages the Company’s ATH treasury strategy.

●

Drug Discovery Services segment: provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples, as well as creation of proprietary 3D culture models used in drug development.

As described in Note 3 – Discontinued Operations, the Company’s former Eagan operating segment met the criteria to be reported as discontinued operations for the first quarter of 2025. As such, the former Eagan operating segment is excluded from the tables below, which only reflect continuing operations for all periods presented.

See discussion of revenue recognition in Note 2 – Summary of Significant Accounting Policies for a description of the products and services recognized in each segment. All revenues are earned from external customers.

The table below summarizes the Company’s segment reporting as of the six months ended June 30, 2026, and the year ended December 31, 2025:

*Compute Services and Treasury Management segment*	June 30, 2026			December 31, 2025
Assets	$	96,017,868		$	49,455,174
Depreciation and amortization		-			-
Expenditures for additions to long-lived assets		(17,100,106	)		-

*Drug Discovery Services segment*
Assets	$	1,634,178		$	1,930,898
Depreciation and amortization		51,425			121,261
Expenditures for additions to long-lived assets		(21,000	)		-

*Corporate*
Assets	$	2,723,910		$	1,502,274
Depreciation and amortization		3,225			7,777
Expenditures for additions to long-lived assets		-			-

*Total*
Assets	$	100,375,956		$	52,888,346
Depreciation and amortization		54,650			129,038
Expenditures for additions to long-lived assets		(17,121,106	)		-

The table below provides a reconciliation of segment revenue and loss for the three and six months ended June 30, 2026 and 2025:

	Three Months Ended June 30,						Six Months Ended June 30,
	2026			2025			2026			2025
*Compute Services and Treasury Management segment*
Revenue	$	3,207,345		$	-		$	3,214,280		$	-
Gains and (losses) from operations		(13,125,352	)		-			(17,421,620	)		-
Cost of operations (a)		4,098,199			-			4,289,848			-
Total operating (loss)		(14,016,206	)		-			(18,497,187	)		-
Segment (loss)		(14,016,206	)		-			(18,497,187	)		-

*Drug Discovery Services segment*
Revenue		7,647			2,682			36,023			112,992
Gains and (losses) from operations		-			-			-			-
Cost of operations (a)		930,704			899,077			1,944,940			1,876,810
Total operating (loss)		(923,057	)		(896,395	)		(1,908,917	)		(1,763,818	)
Segment (loss)		(923,057	)		(896,395	)		(1,908,917	)		(1,763,818	)

*Corporate*
Revenue		-			-			-			-
Gains and (losses) from operations		-			-			-			-
Cost of operations (a) (b)		2,388,747			1,763,473			4,650,586			3,183,097
Total operating (loss)		(2,388,747	)		(1,763,473	)		(4,650,586	)		(3,183,097	)
Segment (loss)		(2,388,747	)		(1,763,473	)		(4,650,586	)		(3,183,097	)

*Total*
Revenue		3,214,992			2,682			3,250,303			112,992
Gains and (losses) from operations		(13,125,352	)		-			(17,421,620	)		-
Cost of operations (a)		7,417,650			2,662,550			10,885,374			5,059,907
Total operating (loss)		(17,328,010	)		(2,659,868	)		(25,056,691	)		(4,946,915	)
Other segment items		122,128			589,406			141,866			433,580
Net (loss)		(17,205,882	)		(2,070,462	)		(24,914,825	)		(4,513,335	)

(a)

Segment cost of operations includes cost of revenues, general and administrative expenses, research and development expenses, and sales and marketing expenses.

(b)

Corporate expenses include general and administrative costs, stock-based compensation, and other items not allocated to the segments.

The entire disclosure for segment reporting.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 34
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-34

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-15

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 15: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 18: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 19: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 20: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 21: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 22: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/280/tableOfContent

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - $ / shares	Jun. 30, 2026	Dec. 31, 2025
Preferred Stock, Shares Authorized (in shares)	20,000,000	20,000,000
Common Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.01	$ 0.01
Common Stock, Shares Authorized (in shares)	200,000,000	200,000,000
Common Stock, Shares, Outstanding (in shares)	11,384,940	4,083,173
Common Stock, Shares, Issued (in shares)	11,384,940	4,083,173
Series B Convertible Preferred Stock [Member]
Preferred Stock, Shares Authorized (in shares)	2,300,000	2,300,000
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.01	$ 0.01
Preferred Stock, Shares Outstanding (in shares)	79,246	79,246

Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S45
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(20))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.6-05(4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(4)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(16)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(7))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.

Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(19))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.6-05(4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(4)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(16)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(7))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Note 8 - Commitments And Contingencies (Details Textual) - Compute Agreements [Member]	3 Months Ended
	Jun. 30, 2026
Minimum [Member]
Contractual Obligation, Term (Month)	12 months
Maximum [Member]
Contractual Obligation, Term (Month)	36 months

Note 6 - Fair Value Measurements (Details Textual) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2026 USD ($)	Dec. 31, 2025 USD ($)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	$ 0	$ 0
Aethir (ATH) [Member] \| Minimum [Member] \| Measurement Input, Discount Rate [Member]
Embedded Derivative Asset, Measurement Input	0.20	0.30
Aethir (ATH) [Member] \| Maximum [Member] \| Measurement Input, Discount Rate [Member]
Embedded Derivative Asset, Measurement Input	0.45	0.55

Note 14 - Segment Information (Tables)

6 Months Ended

Jun. 30, 2026

Segment Reporting [Table Text Block]

*Compute Services and Treasury Management segment*	June 30, 2026			December 31, 2025
Assets	$	96,017,868		$	49,455,174
Depreciation and amortization		-			-
Expenditures for additions to long-lived assets		(17,100,106	)		-

*Drug Discovery Services segment*
Assets	$	1,634,178		$	1,930,898
Depreciation and amortization		51,425			121,261
Expenditures for additions to long-lived assets		(21,000	)		-

*Corporate*
Assets	$	2,723,910		$	1,502,274
Depreciation and amortization		3,225			7,777
Expenditures for additions to long-lived assets		-			-

*Total*
Assets	$	100,375,956		$	52,888,346
Depreciation and amortization		54,650			129,038
Expenditures for additions to long-lived assets		(17,121,106	)		-

	Three Months Ended June 30,						Six Months Ended June 30,
	2026			2025			2026			2025
*Compute Services and Treasury Management segment*
Revenue	$	3,207,345		$	-		$	3,214,280		$	-
Gains and (losses) from operations		(13,125,352	)		-			(17,421,620	)		-
Cost of operations (a)		4,098,199			-			4,289,848			-
Total operating (loss)		(14,016,206	)		-			(18,497,187	)		-
Segment (loss)		(14,016,206	)		-			(18,497,187	)		-

*Drug Discovery Services segment*
Revenue		7,647			2,682			36,023			112,992
Gains and (losses) from operations		-			-			-			-
Cost of operations (a)		930,704			899,077			1,944,940			1,876,810
Total operating (loss)		(923,057	)		(896,395	)		(1,908,917	)		(1,763,818	)
Segment (loss)		(923,057	)		(896,395	)		(1,908,917	)		(1,763,818	)

*Corporate*
Revenue		-			-			-			-
Gains and (losses) from operations		-			-			-			-
Cost of operations (a) (b)		2,388,747			1,763,473			4,650,586			3,183,097
Total operating (loss)		(2,388,747	)		(1,763,473	)		(4,650,586	)		(3,183,097	)
Segment (loss)		(2,388,747	)		(1,763,473	)		(4,650,586	)		(3,183,097	)

*Total*
Revenue		3,214,992			2,682			3,250,303			112,992
Gains and (losses) from operations		(13,125,352	)		-			(17,421,620	)		-
Cost of operations (a)		7,417,650			2,662,550			10,885,374			5,059,907
Total operating (loss)		(17,328,010	)		(2,659,868	)		(25,056,691	)		(4,946,915	)
Other segment items		122,128			589,406			141,866			433,580
Net (loss)		(17,205,882	)		(2,070,462	)		(24,914,825	)		(4,513,335	)

Tabular disclosure of segment reporting. Includes, but is not limited to, reconciliation of reportable segment amount to corresponding consolidated total.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 34
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-34

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26A

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-15

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flow from continuing operating activities:
Net loss	$ (24,914,825)	$ (4,513,335)
Less: (loss) from discontinued operations	0	(249,024)
Net loss from continuing operations	(24,914,825)	(4,264,311)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	54,650	65,222
Amortization of operating lease right-of-use assets	307,143	271,099
Non-cash write off of accounts payable and related accrued expenses	0	(676,678)
Share-based compensation	682,942	0
Issuance of shares to non-employees	0	66,667
Cost of booking compute using digital assets	942,567	0
Losses on digital assets	17,421,620	0
Changes in assets and liabilities:
Accounts receivable	(3,289,306)	11,197
Inventories	0	3,054
Other prepaid expense and other assets	(592,519)	(297,818)
Compute prepayments	(34,095,742)	0
Accounts payable	653,430	511,791
Accrued expenses and other liabilities	(95,406)	371,361
Contract liabilities	60,610,596	(75,000)
Operating lease liability	(314,911)	(267,216)
Net cash provided by (used in) continuing operating activities:	17,370,239	(4,280,632)
Cash flow from continuing investing activities:
Purchase of property and equipment	(17,121,106)	0
Net cash (used in) continuing investing activities:	(17,121,106)	0
Cash flow from continuing financing activities:
Proceeds from issuance of common stock and warrants	10,844,932	3,165,365
Costs to issue common stock and warrants	(210,687)	(202,820)
Payments for taxes related to net share settlement of restricted stock units	(74,121)	0
Proceeds from issuance of financing note payable	413,611	264,048
Repayment of note payable	(107,951)	0
Net cash provided by continuing financing activities	10,865,784	3,226,593
Discontinued operations:
Net cash provided by operating activities	0	200,444
Net cash provided by investing activities	0	625,000
Net cash provided by (used in) financing activities	0	0
Net cash provided by (used in) discontinued operations	0	825,444
Net increase (decrease) in cash	11,114,917	(228,595)
Cash and cash equivalents from continuing operations at beginning of period	10,790,850	611,822
Cash and cash equivalents from discontinued operations at beginning of period	0	122,851
Less: Cash from discontinued operations at end of period	0	0
Cash and cash equivalents from continuing operations at end of period	21,905,767	506,078
Supplemental disclosure for cash flow information:
Cash payments for interest	2,982	1,797
Non-cash transactions:
Common stock issued as prepayment for services	0	33,333
Non-cash transfer from prepaid to property and equipment	(10,500)	0
Shares issued for vested RSUs, net of shares withheld for taxes	396	0
Realized loss on digital assets	$ 1,329,854	$ 0

Note 3 - Discontinued Operations (Tables)

6 Months Ended

Jun. 30, 2026

Schedule of Disposal Group by Balance Sheet Classification [Table Text Block]

	June 30, 2025
Assets:
Accounts receivable, net	$	37,297
Prepaid expense and other assets		10,426
Total current assets of discontinued operations		47,723

Other long-term assets		4,031
Total assets of discontinued operations	$	51,754

Liabilities:
Accounts payable	$	1,149
Accrued expenses and other liabilities		252,015
Lease liability		89,040
Total current liabilities of discontinued operations		342,204

Total liabilities	$	342,204

Disposal Groups, Including Discontinued Operations [Table Text Block]

	For the three months ended June 30, 2025			For the six months ended June 30, 2025
Revenue	$	-		$	157,179
Cost of sales		-			122,800
Gross profit from discontinued operations		-			34,379

Operating expenses:
General and administrative		101,103			204,341
Research and development		2,669			125,495
Sales and marketing		-			130,318
Total operating expenses		103,772			460,154
Total operating (loss) from discontinued operations		(103,772	)		(425,775	)
Gain on disposal of discontinued operations		-			172,451
Other (expense)		12,205			4,300
Net (loss) from discontinued operations	$	(91,567	)	$	(249,024	)

Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-3

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 102
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483474/205-20-55-102

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483475/205-20-45-11

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 103
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483474/205-20-55-103

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5C
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480781/205-20-S99-3

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-4B

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-3

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-1

Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-1

Note 8 - Commitments And Contingencies

6 Months Ended

Jun. 30, 2026

Commitments and Contingencies Disclosure [Text Block]

NOTE 8 – COMMITMENTS AND CONTINGENCIES

Commitments

During the three months ended June 30, 2026, the Company entered into several agreements with third-party vendors to reserve and obtain access to GPU compute capacity, related storage, networking, and support services. Management has evaluated these arrangements and concluded that they are service commitments and not leases. Under these arrangements, the Company is generally required to make upfront payments and, following service commencement or operational activation, monthly service payments over contract terms ranging from 12 to 36 months. These arrangements represent total contractual commitments to be paid according to the following schedule:

2026 (remaining 6 months)	$	16,757,954
2027		107,744,100
2028		99,220,630
2029		38,852,831
Total	$	262,575,515

Litigation

In the ordinary course of business, the Company may be subject from time to time to various proceedings, lawsuits, disputes, or claims. In accordance with ASC 450, Contingencies (“ASC 450”), the Company accrues a liability for legal contingencies when it is probable that a liability has been incurred, and the amount of the loss can be reasonably estimated. If there is at least a reasonable possibility that a loss may be incurred, ASC 450 requires disclosure of a loss contingency.

There have been no material changes to the Company’s contingencies as disclosed in the Form 10-K for the year ended December 31, 2025.

Note 7 - Property and Equipment, Net (Details Textual) - USD ($)		3 Months Ended			6 Months Ended
	Jun. 30, 2026	Jun. 30, 2026	Mar. 31, 2026	Mar. 31, 2025	Jun. 30, 2026	Jun. 30, 2025
Depreciation	$ 52,361					$ 62,934
Payments to Acquire Property, Plant, and Equipment					$ 17,121,106	$ (0)
Equipment [Member]
Payments to Acquire Property, Plant, and Equipment		$ 17,100,000
Property, Plant and Equipment [Member]
Asset Impairment Charges			$ 0	$ 0

Insider Trading Arrangements	6 Months Ended
Insider Trading Arrangements	Jun. 30, 2026
Trading Arrangements, by Individual [Table]
Material Terms of Trading Arrangement [Text Block]	ITEM 5. OTHER INFORMATION Not applicable.
Rule 10b5-1 Arrangement Adopted [Flag]	false
Non-Rule 10b5-1 Arrangement Adopted [Flag]	false
Rule 10b5-1 Arrangement Terminated [Flag]	false
Non-Rule 10b5-1 Arrangement Terminated [Flag]	false

Note 10 - Note Payable

6 Months Ended

Jun. 30, 2026

Debt Disclosure [Text Block]

NOTE 10 – NOTE PAYABLE

In June 2026, the Company purchased director and officer insurance policies with a policy period ending June 2027 and financed $0.4 million of its total premium by entering into a note payable with a finance provider that requires ten monthly installment payments through April 2027. The note is secured by a first priority lien on the financed policies. The short-term note bears interest at an annual percentage rate of 6.1% over the life of the note. As of June 30, 2026, the outstanding balance of the note was $0.4 million including interest.

In June 2025, the Company purchased director and officer insurance policies with a policy period ending June 2026 and financed $0.3 million of its total premium by entering into a note payable with a finance provider that required ten monthly installment payments through April 2026. The note was secured by a first priority lien on the financed policies. The short-term note bears interest at an annual percentage rate of 6.6% over the life of the note. As of December 31, 2025, the outstanding balance of the note was $0.1 million including interest.

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(16))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480657/210-10-S50-8

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(19)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22)(a)(4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22)(a)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22)(a)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(19))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480657/210-10-S50-9

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481544/470-10-50-6

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481544/470-10-50-6

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 470
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/470/tableOfContent

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Note 4 - Revenue Recognition and Contracts with Customers (Details)	Jun. 30, 2026 USD ($)
Revenue, Remaining Performance Obligation	$ 60,754,672

Note 3 - Discontinued Operations

6 Months Ended

Jun. 30, 2026

Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]

NOTE 3 – DISCONTINUED OPERATIONS

On March 14, 2025, the Company entered into an asset purchase agreement (the “APA”) and closed the transactions contemplated therein with DeRoyal Industries, Inc., a Tennessee corporation (“DeRoyal”), to sell and assign to DeRoyal assets and liabilities exclusively related to the business of providing products for automated, direct-to-drain medical fluid disposal, including the Company’s STREAMWAY® product line (the “Eagan Business”). These assets were operated by the Company’s wholly owned subsidiary, Skyline Medical, and were previously reported in the Company’s Eagan operating segment. The purchased assets exclusively related to the Eagan Business included but were not limited to cash, certain accounts receivable, inventories, patents, fixed assets, and real property leased by the Company and exclusively used in connection with the Eagan Business. The total purchase price for the assets was $625,000, plus the assumption of certain liabilities related to the Eagan Business including the lease for the office and warehouse space located at 2915 Commers Drive Suite 900 Eagan, MN 55121, certain accounts payable, and contract liabilities associated with the Eagan Business. The ongoing activities of the former Eagan operating segment are limited to wind down activities. As a result of these developments, the former Eagan operating segments have been reclassified to discontinued operations in these condensed consolidated financial statements for all periods presented.

The balance sheet as of June 30, 2026, does not include any assets and liabilities of discontinued operations. The following table presents a reconciliation of the carrying amounts of the major classes of assets and liabilities to the current assets and liabilities of discontinued operations as presented in the Company’s condensed consolidated balance sheet as of June 30, 2025:

	June 30, 2025
Assets:
Accounts receivable, net	$	37,297
Prepaid expense and other assets		10,426
Total current assets of discontinued operations		47,723

Other long-term assets		4,031
Total assets of discontinued operations	$	51,754

Liabilities:
Accounts payable	$	1,149
Accrued expenses and other liabilities		252,015
Lease liability		89,040
Total current liabilities of discontinued operations		342,204

Total liabilities	$	342,204

The statement of net loss as of June 30, 2026, does not include any discontinued operation activity. The following table provides details about the major classes of line items constituting the loss from discontinued operations presented in the Company’s condensed consolidated statement of net loss for the three and six months ended June 30, 2025:

	For the three months ended June 30, 2025			For the six months ended June 30, 2025
Revenue	$	-		$	157,179
Cost of sales		-			122,800
Gross profit from discontinued operations		-			34,379

Operating expenses:
General and administrative		101,103			204,341
Research and development		2,669			125,495
Sales and marketing		-			130,318
Total operating expenses		103,772			460,154
Total operating (loss) from discontinued operations		(103,772	)		(425,775	)
Gain on disposal of discontinued operations		-			172,451
Other (expense)		12,205			4,300
Net (loss) from discontinued operations	$	(91,567	)	$	(249,024	)

The gain on disposal of discontinued operations represents the gain on assets sold and liabilities assumed by DeRoyal.

Note 13 - Net Loss Per Share (Tables)

6 Months Ended

Jun. 30, 2026

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

	Three Months Ended June 30,						Six Months Ended June 30,
	2026			2025			2026			2025
Numerator:
Net (loss) from continuing operations	$	(17,205,882	)	$	(1,978,896	)	$	(24,914,825	)	$	(4,264,311	)
Net (loss) from discontinued operations		-			(91,567	)		-			(249,024	)
Net (loss) attributable to common stockholders		(17,205,882	)		(2,070,462	)		(24,914,825	)		(4,513,335	)

Denominator:
Weighted average common shares outstanding - basic		19,685,811			9,108,984			17,167,696			8,136,008
Dilutive effect of stock options, warrants and preferred stock (1)		-			-			-			-
Weighted average common shares outstanding - diluted		19,685,811			9,108,984			17,167,696			8,136,008

Net (loss) from continuing operations attributable to common stockholders per common share – basic and diluted		(0.87	)		(0.22	)		(1.45	)		(0.52	)
Net (loss) from discontinued operations attributable to common stockholders per common share – basic and diluted		-			(0.01	)		-			(0.03	)
(Loss) per common share - basic and diluted		(0.87	)		(0.23	)		(1.45	)		(0.55	)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Options		1,027,918		42,113		1,027,918		42,113
Warrants		1,617,043		940,412		1,617,043		940,412
Restricted stock units		-		-		-		-
Preferred stock: Series B		2		2		2		2

Note 6 - Fair Value Measurements

6 Months Ended

Jun. 30, 2026

Fair Value Disclosures [Text Block]

NOTE 6 – FAIR VALUE MEASUREMENTS

The following tables present information about the Company’s financial assets and liabilities measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value as of June 30, 2026 and December 31, 2025, respectively. Fair value estimates do not necessarily represent the amounts that may be ultimately realized.

June 30, 2026	Fair Value			Level 1		Level 2		Level 3
Assets:
Cash equivalents	$	20,000,000		$	20,000,000	$	-	$	-
Digital assets		11,268,342			11,268,342		-		-
Embedded derivative related to digital asset receivable	$	(83,086,868	)	$	-	$	-	$	(83,086,868	)

December 31, 2025	Fair Value			Level 1		Level 2		Level 3
Assets:
Digital assets	$	24,439,598		$	24,439,598	$	-	$	-
Embedded derivative related to digital asset receivable	$	(77,893,482	)	$	-	$	-	$	(77,893,482	)

Cash equivalents represent the Company’s money market investments. The fair value of these investments is based on the daily market price for identical assets in active markets.

The embedded derivative related to the digital asset receivable must be remeasured at fair value each reporting period in accordance with ASC 815, Derivatives and Hedging. Because there is no directly observable market for illiquid, contractually restricted ATH tokens subject to a time-based vesting schedule, the embedded derivative related to digital asset receivable is classified as Level 3. The key unobservable input is the discount applied to reflect the lack of transferability and control during the restriction period. The discount is determined based on the remaining vesting period from each reporting period to the date on which the tokens become fully vested and available to claim, and is reduced ratably at each subsequent measurement date until it reaches zero at full vesting. As of the six months ended June 30, 2026, applied discounts ranged from approximately 20% to 45%. As of December 31, 2025, applied discounts ranged from approximately 30% to 55%. Changes in fair value of the embedded derivative are recognized in the consolidated statements of net loss within "Gains (losses) on digital assets." There were no transfers into or out of Level 3 of the fair value hierarchy during the six months ended June 30, 2026, or the year ended December 31, 2025.

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 107
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-107

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 100
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-100

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 940
-SubTopic 820
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478119/940-820-50-1

Note 7 - Property and Equipment, Net

6 Months Ended

Jun. 30, 2026

Property, Plant, and Equipment [Text Block]

NOTE 7 – PROPERTY AND EQUIPMENT, NET

The Company’s property and equipment, net consisted of the following:

	As of June 30, 2026			As of December 31, 2025
Computers, software, and office equipment	$	170,350		$	170,350
Construction in progress - Technology equipment		17,100,106			-
Leasehold improvements		166,847			166,847
Laboratory equipment		1,713,230			1,692,230
Total		19,150,533			2,029,427
Less: Accumulated depreciation		(1,858,660	)		(1,806,299	)
Total Property and equipment, net	$	17,291,873		$	223,128

Depreciation expense, recorded within general and administrative expenses of continuing operations, was $25,089 and $31,467 for the three months ended June 30, 2026 and 2025, respectively, and $52,361 and $62,934 for the six months ended June 30, 2026 and 2025, respectively.

During the three months ended June 30, 2026, the Company purchased $17.1 million of technology equipment related to the infrastructure solutions model within the compute services business. As of June 30, 2026, the entirety of the technology equipment balance represents construction in progress.

No impairment charges related to property and equipment held and used in continuing operations were incurred during the three and six months ended June 30, 2026 and 2025.

The entire disclosure for property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-3

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 360
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/360/tableOfContent

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482130/360-10-45-13

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.CC)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-SubTopic 360
-Topic 958
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477798/958-360-50-6

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-SubTopic 360
-Topic 958
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477798/958-360-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-SubTopic 360
-Topic 958
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477798/958-360-50-7

Note 1 - Company Information

6 Months Ended

Jun. 30, 2026

Business Description and Basis of Presentation [Text Block]

NOTE 1 – COMPANY INFORMATION

Nature of Operations

Axe Compute Inc. is a technology company focused on providing high-performance computing infrastructure for artificial intelligence (“AI”) workloads by sourcing large-scale graphics processing unit (“GPU”) capacity from hardware manufacturers and infrastructure suppliers and deploying that capacity for enterprise customers under long-term service agreements. The Company assists customers across the full GPU infrastructure stack, including hardware procurement, colocation, networking, storage, and financing, and can immediately access compute capacity through relationships with third party compute providers to provide customers compute capacity that is already online and available for rent. The Company also continues to evaluate strategic alternatives for its legacy oncology drug discovery business (the “Legacy Business”), including its proprietary biobank of tumor samples and historical drug response data, which is not part of the Company’s core compute infrastructure operations.

Compute Services

The Company’s principal revenue-generating activity is the provision of GPU compute to customers. The Company primarily provides compute services under two customer models: (1) designing and deploying customized, large scale compute infrastructure solutions for enterprise clients; and (2) providing immediate access to GPU capacity (in as little as 24-48 hours) that is already online and available for rent from third parties.

For customers seeking large-scale, long-duration GPU compute capacity, the Company builds and deploys dedicated compute infrastructure solutions. Under this model, customers contract for dedicated AI infrastructure tailored to their compute, performance, geographic, security, and operational requirements. The Company coordinates with customers to architect deployments that may include GPU compute, high-speed storage, networking, power infrastructure, and related managed services. Deployments are typically hosted in enterprise-grade data center facilities and are operated by the Company pursuant to service level commitments. The Company intends to finance and then retain ownership of the deployed hardware and related infrastructure, while providing customers access to the infrastructure through multi-year service agreements. Customer contracts are typically structured with deposits, prepayments, and recurring monthly payments, including take-or-pay provisions intended to provide income visibility throughout the contract term.

For customers that need immediate access to GPU compute capacity, the Company provides access to high-performance GPU compute infrastructure. Our access to third-party networks encompasses global locations and GPUs capable of supporting a broad range of artificial intelligence, machine learning, and high-performance computing workloads. Compute capacity is delivered to customers through a managed infrastructure model, typically within 48 hours of customer engagement, without requiring customers to make capital investments in physical hardware or data center facilities.

Drug Discovery Services / Legacy Business

The provision of compute services is the priority of the Company and remains its focus. The Company also maintains its legacy oncology drug discovery solutions business, which was previously conducted under the Predictive Oncology Inc. name. Current operations in this business are limited, and the Company is exploring strategic alternatives, including a potential sale or other disposition, although no definitive plan has been approved. Historically, this business applied AI to support the discovery and development of cancer therapies, with the objective of improving treatment effectiveness and patient outcomes. The business leveraged AI capabilities to provide actionable insights about drug compounds to improve the drug discovery process and increase the probability of drug compound success. In February 2026, the Company announced that it is exploring strategic alternatives for this oncology drug discovery solutions business. However, as of the date of this Quarterly Report on Form 10-Q, the Company’s Board of Directors has not yet committed to a specific course of action.

For further discussion of the Company’s operating segments as of and for the six months ended June 30, 2026, see Note 14 – Segment Information.

Strategic Compute Reserve

On September 29, 2025, the Company adopted a treasury strategy centered on ATH, the native utility token of the Aethir network. Aethir is a decentralized physical infrastructure network developed by DCI Foundation, a Panama foundation company ("DCI"), that aggregates enterprise-grade GPU resources to support artificial intelligence, cloud gaming and other compute-intensive workloads. ATH functions as a proxy for a unit of GPU compute power and serves as the medium of exchange and incentive mechanism for participants in the Aethir network.

Under this strategy, the Company maintains a Strategic Compute Reserve comprised primarily of ATH, which provides the Company with immediate access to GPU compute capacity that can be deployed to customers. As a holder of ATH, the Company accrues unrealized gains or losses from any appreciation or depreciation, as applicable, in the value of ATH tokens, which trade on various cryptocurrency exchanges.

The Company seeks to generate value from its ATH holdings principally by utilizing ATH to procure GPU compute capacity on the Aethir network and reselling that capacity to enterprise, research and commercial customers. The Company has not engaged in ATH staking to date and does not currently intend to stake ATH, although it may elect to do so in the future.

The Company's Strategic Compute Reserve is intended to create value for stockholders through:

●

Maintaining access to GPU compute capacity through ownership of ATH;

●

Deploying ATH to acquire compute capacity and reselling that capacity to customers;

●

Opportunistically purchasing ATH in the open market, including receiving additional ATH incentives under the DCI agreement;

●

Earning yield through lending arrangements and other approved treasury activities;

●

Holding ATH as a strategic reserve to support future compute demand; and

●

Selling ATH from time to time to support working capital requirements, operational needs or other corporate purposes.

Refer to "Risks and Uncertainties" below for further discussion regarding risks related to the Company's Strategic Compute Reserve.

Liquidity

Since the adoption of the Company’s treasury strategy based on ATH, the Company has raised capital through private investment in public equity (“PIPE”) transactions and at-the-market (“ATM”) sales of shares of common stock. Additional details regarding these equity offerings are included in Note 11 – Stockholders’ Equity. These capital raises have strengthened the Company’s liquidity position, and the $21.9 million of cash and cash equivalents remaining as of June 30, 2026, together with $11.3 million of digital assets, represent readily accessible sources of liquidity. The Company believes its sources of liquidity will be sufficient to allow the Company to fund its planned operations for at least the next twelve months from the date of this Quarterly Report on Form 10-Q.

Reverse Stock Split

On September 19, 2025, the Company’s stockholders approved an amendment to the Company’s certificate of incorporation, as amended, to effect a one-for-fifteen reverse stock split of the Company’s common stock. On September 29, 2025, the Company completed a one-for-fifteen reverse stock split that was effective for trading purposes on September 30, 2025 (the “Reverse Stock Split”). All numbers of shares and per-share amounts in this report have been adjusted to reflect the Reverse Stock Split.

As a result of the Reverse Stock Split, every 15 shares of issued and outstanding common stock were combined into one issued and outstanding share of common stock, without any change in the par value per share. No fractional shares were issued as a result of the Reverse Stock Split and any fractional shares that would otherwise have resulted from the Reverse Stock Split were rounded up to the nearest whole share. The Reverse Stock Split did not change the total number of authorized shares of common stock or preferred stock.

Note 5 - Digital Assets - Crypto Asset, Holding (Details)	Jun. 30, 2026 USD ($)	Mar. 31, 2026 USD ($)	Dec. 31, 2025 USD ($)
Units Held	2,655,414,499
Cost Basis	$ 94,739,253
Fair Value	11,144,775
Aethir (ATH) [Member]
Units Held			2,837,163,868
Cost Basis			$ 101,258,178
Fair Value	$ 11,144,775	$ 20,233,245	$ 24,439,334

Note 3 - Discontinued Operations - Schedule of Disposal Groups Including Discontinued Operations (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Less: (loss) from discontinued operations	$ 0	$ (91,567)	$ 0	$ (249,024)
Discontinued Operations, Disposed of by Sale [Member] \| Birmingham Laboratory and Eagan Business [Member]
Revenue		0		157,179
Cost of sales		0		122,800
Gross profit from discontinued operations		0		34,379
General and administrative		101,103		204,341
Operations, research and development		2,669		125,495
Sales and marketing		0		130,318
Total operating expenses		103,772		460,154
Total operating (loss) from discontinued operations		(103,772)		(425,775)
Gain/(loss) on disposal of discontinued operations		0		172,451
Other (expense)		12,205		4,300
Less: (loss) from discontinued operations		$ (91,567)		$ (249,024)

Note 4 - Revenue Recognition and Contracts with Customers (Tables)

6 Months Ended

Jun. 30, 2026

Schedules of Concentration of Risk, by Risk Factor [Table Text Block]

Three Months Ended June 30,

Six Months Ended June 30,

2026

2025

2026

2025

Customer A

Customer B

Customer C

Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]

	June 30, 2026			June 30, 2025
Balance, beginning of period	$	144,076		$	224,076
Advance billings		63,822,941			-
Revenue recognized		(3,212,345	)		(75,000	)
Balance, end of period	$	60,754,672		$	149,076

Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]

2026 (remaining 6 months)	$	29,301,246
2027		7,053,109
2028		1,906,741
2029		22,493,576
	$	60,754,672

Note 13 - Net Loss Per Share

6 Months Ended

Jun. 30, 2026

Earnings Per Share [Text Block]

NOTE 13 – NET LOSS PER SHARE

Earnings per share accounting requires the presentation of both basic and diluted earnings per share on the face of the statements of net loss. The Company calculates basic net loss per share based upon the weighted average number of common shares outstanding during the period, while the calculation of diluted earnings per share includes the dilutive effect of potential common shares outstanding during the period. The calculation of diluted earnings per share excludes all potential common shares, with the exception of pre-funded warrants, if their inclusion would have an anti-dilutive effect. A total of 9,972,424 pre-funded warrants is included in the computation of earnings per share because the exercise price of the pre-funded warrants is nominal and there are no conditions that must be satisfied prior to their exercise.

The following table presents the shares used in the basic and diluted loss per common share computations:

	Three Months Ended June 30,						Six Months Ended June 30,
	2026			2025			2026			2025
Numerator:
Net (loss) from continuing operations	$	(17,205,882	)	$	(1,978,896	)	$	(24,914,825	)	$	(4,264,311	)
Net (loss) from discontinued operations		-			(91,567	)		-			(249,024	)
Net (loss) attributable to common stockholders		(17,205,882	)		(2,070,462	)		(24,914,825	)		(4,513,335	)

Denominator:
Weighted average common shares outstanding - basic		19,685,811			9,108,984			17,167,696			8,136,008
Dilutive effect of stock options, warrants and preferred stock (1)		-			-			-			-
Weighted average common shares outstanding - diluted		19,685,811			9,108,984			17,167,696			8,136,008

Net (loss) from continuing operations attributable to common stockholders per common share – basic and diluted		(0.87	)		(0.22	)		(1.45	)		(0.52	)
Net (loss) from discontinued operations attributable to common stockholders per common share – basic and diluted		-			(0.01	)		-			(0.03	)
(Loss) per common share - basic and diluted		(0.87	)		(0.23	)		(1.45	)		(0.55	)

(1)

The following is a summary of the number of underlying shares outstanding at the end of the respective periods that have been excluded from the diluted calculations because the effect on loss per common share would have been anti-dilutive:

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Options		1,027,918		42,113		1,027,918		42,113
Warrants		1,617,043		940,412		1,617,043		940,412
Restricted stock units		-		-		-		-
Preferred stock: Series B		2		2		2		2

Note 4 - Revenue Recognition and Contracts with Customers - Schedule of Contract Balances (Details) - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Balance	$ 144,076	$ 224,076
Advance billings	63,822,941	0
Revenue recognized	(3,212,345)	(75,000)
Balance	$ 60,754,672	$ 149,076

Note 14 - Segment Information - Segments (Details) - USD ($)

3 Months Ended

6 Months Ended

12 Months Ended

Jun. 30, 2026

Jun. 30, 2025

Jun. 30, 2026

Jun. 30, 2025

Dec. 31, 2025

$ 100,375,956

$ 52,888,346

3,214,992

$ 2,682

3,250,303

$ 112,992

54,650

129,038

(17,121,106)

(13,125,352)

(17,421,620)

^[1]

7,417,650

2,662,550

10,885,374

5,059,907

(17,328,010)

(2,659,868)

(25,056,691)

(4,946,915)

Operating Segments [Member] | Compute Services and Treasury Management Segment [Member]

(17,205,882)

(2,070,462)

(24,914,825)

(4,513,335)

Other segment items

122,128

589,406

141,866

433,580

96,017,868

49,455,174

3,207,345

3,214,280

(17,100,106)

(13,125,352)

(17,421,620)

^[1]

4,098,199

4,289,848

(14,016,206)

(18,497,187)

Operating Segments [Member] | Drug Discovery Services Segment [Member]

(14,016,206)

(18,497,187)

1,634,178

1,930,898

7,647

2,682

36,023

112,992

51,425

121,261

(21,000)

^[1]

930,704

899,077

1,944,940

1,876,810

(923,057)

(896,395)

(1,908,917)

(1,763,818)

Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]

(923,057)

(896,395)

(1,908,917)

(1,763,818)

2,723,910

1,502,274

3,225

7,777

$ 0

^[1],[2]

2,388,747

1,763,473

4,650,586

3,183,097

(2,388,747)

(1,763,473)

(4,650,586)

(3,183,097)

$ (2,388,747)

$ (1,763,473)

$ (4,650,586)

$ (3,183,097)

[1]	Segment cost of operations includes cost of revenues, general and administrative expenses, research and development expenses, and sales and marketing expenses.
[2]	Corporate expenses include general and administrative costs, stock-based compensation, and other items not allocated to the segments.

Note 12 - Stock-Based Compensation

6 Months Ended

Jun. 30, 2026

Share-Based Payment Arrangement [Text Block]

NOTE 12 – STOCK-BASED COMPENSATION

Equity Incentive Plan

On December 30, 2024, the Company’s stockholders approved the 2024 Equity Incentive Plan (the “2024 Plan”). The 2024 Plan allows for the issuance of non-statutory stock options and incentive stock options, stock appreciation rights, stock awards, restricted stock, restricted stock units, and performance awards to employees, directors, and consultants of the Company, where permitted under the plan. Due to the approval of the 2024 Plan, no new awards will be granted under the Company’s Amended and Restated 2012 Stock Incentive Plan. The exercise price for each stock option is determined by the market price on the date of issuance. Vesting requirements are determined by the Board of Directors when granted and currently range from immediate to three years. Options outstanding under this plan have a contractual life of ten years.

ASC 718, Compensation – Stock Compensation (“ASC 718”), requires that a company that issues equity as compensation record compensation expense that corresponds to the estimated cost of those equity grants. ASC 718 requires companies to estimate the fair value of stock-based payment awards on the date of grant using an option-pricing model or other acceptable means.

Restricted Stock Units

On September 9, 2025, the Board of Directors, upon the recommendation of the Compensation Committee of the Board of Directors (the “Compensation Committee”), determined that it was appropriate to award restricted stock units (“RSUs”) as a form of compensation for employees, consultants and directors and approved a form of Restricted Stock Unit Award Agreement, with such awards to be granted under the Company’s 2024 Plan. Consistent with that determination, the Board of Directors approved the grant of 60,101 RSUs on September 9, 2025. Each RSU represented the right to receive one share of the Company’s common stock upon vesting. The RSUs contained a service-based vesting condition requiring continued service through October 31, 2025, at which point the RSUs vested in full. The RSUs were settled on November 28, 2025.

On December 10, 2025, the Company entered into an amendment to the employment agreement with Raymond F. Vennare dated as of November 1, 2022. Pursuant to the amendment and following approval by the Compensation Committee, Mr. Vennare was awarded 20,000 RSUs. The RSUs contained a service-based vesting condition requiring continued service through January 1, 2026, at which point the RSUs vested in full. The RSUs were settled on February 5, 2026.

During the six months ended June 30, 2026, 33,330 additional RSUs were granted to employees and consultants under the Company’s 2024 Plan. Each RSU represented the right to receive one share of the Company’s common stock upon vesting. The RSUs vested in full upon the RSU grant date.

The following table summarizes the Company’s RSU activity for the period indicated:

	Number of Shares			Weighted-Average Grant Date Fair Value per RSU
Non-vested RSUs as of December 31, 2025		20,000		$	5.92
Granted		33,330		$	5.84
Vested		(53,330	)	$	5.86
Non-vested RSUs as of June 30, 2026		-

The Company has no unrecognized stock-based compensation expense related to RSUs that is expected to be recognized in a future period.

Stock Options

The Company determines the grant date fair value of options and warrants using a Black-Scholes option valuation model based upon assumptions regarding risk-free interest rate, expected dividend rate, volatility, and estimated term. There were 1,025,000 stock options granted for the six months ended June 30, 2026. There were no stock options granted for the six months ended June 30, 2025.

The following table summarizes the Company’s stock option activity for the period indicated:

	Number of Shares			Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Term (Years)		Aggregate Intrinsic value
Outstanding as of December 31, 2025		2,925		$	1,334.98		2.99		-
Issued		1,025,000		$	1.09		9.67	$	5,372,100
Expired		(7	)	$	12,107.14		-		-
Exercised		-			-		-		-
Outstanding as of June 30, 2026		1,027,918		$	6.05		9.65	$	5,372,100

The fair value of each option grant for the six months ended June 30, 2026 and 2025, was estimated on the grant date using the Black-Scholes option valuation model with the following assumptions:

	Six Months Ended June 30,
	2026			2025
Expected dividend yield		0.0	%		0.0	%
Expected stock price volatility		99.4% - 103.5	%		99.4	%
Risk-free interest rate		4.22% - 4.33	%		4.37	%
Expected life (in years)	10			5

The Company has $1.9 million of unrecognized stock-based compensation expense related to stock options that is expected to be recognized over the next approximately three years.

Stock-Based Compensation Expense, Net

Stock-based compensation expense, net of forfeitures, recognized for the three and six months ended June 30, 2026, was $0.6 million and $0.7 million, respectively. There was no stock-based compensation expense recognized for the three and six months ended June 30, 2025. Such expense is included within general and administrative expenses in the condensed consolidated statements of net loss.

Note 12 - Stock-based Compensation - Warrant Valuation Assumption (Details)	Jun. 30, 2026	Jun. 30, 2025
Expected stock price volatility, minimum	99.40%
Expected stock price volatility, maximum	103.50%
Risk-free interest rate, minimum	4.22%
Risk-free interest rate, Maximum	4.33%
Share-Based Payment Arrangement, Option [Member]
Expected dividend yield	0.00%	0.00%
Expected stock price volatility		99.40%
Risk-free interest rate		4.37%

Note 4 - Revenue Recognition and Contracts with Customers

6 Months Ended

Jun. 30, 2026

Revenue from Contract with Customer [Text Block]

NOTE 4 – REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS

Disaggregation of Revenue

The Company primarily generates its revenue through providing GPU compute services for fixed term contracts. Revenue recognized related to fixed term contracts represented substantially all of the revenue for the three and six months ended June 30, 2026.

Contracts with Customers

The following customers accounted for 10% or more of the Company’s revenue for the periods presented:

Three Months Ended June 30,

Six Months Ended June 30,

2026

2025

2026

2025

Customer A

Customer B

Customer C

* Customer did not represent 10% or more of revenue.

Customer A, B, and C accounted for 16%, 13%, and 58% of accounts receivable, net, respectively, as of June 30, 2026. All other single customers represent less than 10% of revenue and accounts receivable, net, for the three and six month periods ended and as of June 30, 2026.

The Company monitors the creditworthiness of its customers on an ongoing basis and believes that its credit risk is limited due to the financial strength and payment history of these customers. Management does not expect any material losses from these receivable concentrations and has not recorded an allowance for doubtful accounts, as all receivables are considered highly collectible.

Contract Balances

The Company’s contract balances are comprised of prepayments received from compute services customers. The Company invoices for services in advance and when the Company receives consideration (or has an unconditional right to consideration) before services are fulfilled, the Company recognizes a contract liability for the unfulfilled performance obligation. These prepayments are classified as contract liabilities until the appropriate revenue recognition criteria have been met. As of June 30, 2026, the Company had contract liabilities of $60.7 million primarily related to compute services. As of December 31, 2025, the Company had contract liabilities of $0.1 million which was all related to Drug Discovery Services.

The following table represents a reconciliation of the changes in the Company’s contract balances:

	June 30, 2026			June 30, 2025
Balance, beginning of period	$	144,076		$	224,076
Advance billings		63,822,941			-
Revenue recognized		(3,212,345	)		(75,000	)
Balance, end of period	$	60,754,672		$	149,076

During the six months ended June 30, 2026, an immaterial amount of revenue was recognized relating to the contract liabilities as of December 31, 2025.

The Company had no contract assets as of the periods presented, as the Company’s right to consideration becomes unconditional upon invoicing (which occurs at or before the service period commences) and does not depend on any factor other than passage of time.

As of June 30, 2026, the Company had $60.8 million of remaining performance obligations. The Company expects to recognize revenue associated with these performance obligations as follows:

2026 (remaining 6 months)	$	29,301,246
2027		7,053,109
2028		1,906,741
2029		22,493,576
	$	60,754,672

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-7

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-9

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-10

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-15

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-13

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Topic 606
-Publisher FASB
-URI https://asc.fasb.org/606/tableOfContent

Note 4 - Revenue Recognition and Contracts with Customers (Details Textual) - USD ($)	6 Months Ended
	Jun. 30, 2026	Dec. 31, 2025	Jun. 30, 2025	Dec. 31, 2024
Contract with Customer, Liability	$ 60,754,672	$ 144,076	$ 149,076	$ 224,076
Revenue, Remaining Performance Obligation, Amount	60,754,672
Compute Services [Member]
Contract with Customer, Liability	$ 60,700,000
Drug Discovery Services [Member[
Contract with Customer, Liability		$ 100,000
Customer A [Member] \| Accounts Receivable [Member] \| Customer Concentration Risk [Member]
Concentration Risk, Percentage	16.00%
Customer B [Member] \| Accounts Receivable [Member] \| Customer Concentration Risk [Member]
Concentration Risk, Percentage	13.00%
Customer C [Member] \| Accounts Receivable [Member] \| Customer Concentration Risk [Member]
Concentration Risk, Percentage	58.00%

Note 2 - Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2026

Significant Accounting Policies [Text Block]

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation and Principles of Consolidation

Discontinued Operations

Accounting Policies and Use of Estimates

Revenues from GPU Compute Services

Property and equipment

The estimated useful lives of the Company’s property and equipment are as follows:

	Years
Technology equipment	5	-	7
Computers, software, and office equipment	3	-	10
Leasehold improvements (1)	1	-	2
Laboratory equipment	4	-	10

(1)	Leasehold improvements are amortized over the shorter of the useful life or the remaining lease term.

Compute prepayments

Risks and Uncertainties

Recently Issued Accounting Pronouncements

Condensed Consolidated Statements of Net Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Revenue	$ 3,214,992	$ 2,682	$ 3,250,303	$ 112,992
Gains (losses) on digital assets	(13,125,352)	0	(17,421,620)	0
Operating costs and expenses:
Cost of revenues	3,013,339	18,221	3,016,195	63,339
General and administrative	2,735,922	1,875,655	5,644,958	3,703,855
Research and development	492,227	499,715	1,039,672	1,020,121
Sales and marketing	1,176,162	268,959	1,184,549	272,592
Total operating costs and expenses	7,417,650	2,662,550	10,885,374	5,059,907
Total operating (loss)	(17,328,010)	(2,659,868)	(25,056,691)	(4,946,915)
Other income	124,220	682,424	144,848	685,852
Other expense	(2,092)	(1,451)	(2,982)	(3,248)
Loss from continuing operations	(17,205,882)	(1,978,896)	(24,914,825)	(4,264,311)
Loss from discontinued operations	0	(91,567)	0	(249,024)
Net (loss)	$ (17,205,882)	$ (2,070,462)	$ (24,914,825)	$ (4,513,335)
Loss from continuing operations (in dollars per share)	$ (0.87)	$ (0.22)	$ (1.45)	$ (0.52)
Loss from discontinued operations (in dollars per share)	0	(0.01)	0	(0.03)
Net (loss) per common share, basic and diluted (in dollars per share)	$ (0.87)	$ (0.23)	$ (1.45)	$ (0.55)
Weighted average shares used in computation – basic and diluted (in shares)	19,685,811	9,108,984	17,167,696	8,136,008

Note 5 - Digital Assets (Details Textual)	3 Months Ended	6 Months Ended	12 Months Ended
Note 5 - Digital Assets (Details Textual)	Jun. 30, 2026 USD ($)	Jun. 30, 2026 USD ($)	Dec. 31, 2025 USD ($)	Mar. 31, 2026 USD ($)	Oct. 07, 2025
Crypto Asset, Fair Value	$ 11,144,775	$ 11,144,775
Non-ATH [Member]
Crypto Asset, Fair Value	100,000	100,000
Aethir (ATH) [Member]
Crypto Asset, Fair Value	11,144,775	11,144,775	$ 24,439,334	$ 20,233,245
Crypto Assets, Lending Arrangement, Operating Income	76,896	76,896
Crypto Asset, Receivable	10,300,000	10,300,000	15,500,000
Crypto Asset, Host Receivable	93,400,000	93,400,000	93,400,000
Embedded Derivative, Fair Value of Embedded Derivative Asset	$ 83,100,000	83,100,000	77,900,000
Embedded Derivative, Gain (Loss) on Embedded Derivative, Net		$ (5,200,000)	$ 77,900,000
Aethir (ATH) [Member] \| Side Letter Agreement [Member]
Bonus Tokens, Percent					20.00%
Aethir (ATH) [Member] \| Aethir Foundation [Member]
Crypto Asset, Number of Crypto Asset Transferred	2,400,000,000	2,400,000,000
Crypto Asset, Lending Arrangement, Accrued Interest Rate		6.00%
Crypto Assets, Lending Arrangement, Operating Income	$ 100,000	$ 100,000
Crypto Assets, Number of Crypto Assets Subject to Lending Arrangement	0	0

Note 3 - Discontinued Operations (Details Textual)	Mar. 14, 2025 USD ($)
Eagan Business [Member]
Disposal Group, Including Discontinued Operation, Consideration	$ 625,000

Note 1 - Company Information (Details Textual)	Sep. 29, 2025	Jun. 30, 2026 USD ($)	Dec. 31, 2025 USD ($)
Cash and Cash Equivalent		$ 21,905,767	$ 10,790,850
Crypto Asset, Fair Value, Current		$ 11,268,342	$ 24,439,598
Reverse Stock Split [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio	15

Note 6 - Fair Value Measurements (Tables)

6 Months Ended

Jun. 30, 2026

Fair Value, Assets Measured on Recurring Basis [Table Text Block]

June 30, 2026	Fair Value			Level 1		Level 2		Level 3
Assets:
Cash equivalents	$	20,000,000		$	20,000,000	$	-	$	-
Digital assets		11,268,342			11,268,342		-		-
Embedded derivative related to digital asset receivable	$	(83,086,868	)	$	-	$	-	$	(83,086,868	)

December 31, 2025	Fair Value			Level 1		Level 2		Level 3
Assets:
Digital assets	$	24,439,598		$	24,439,598	$	-	$	-
Embedded derivative related to digital asset receivable	$	(77,893,482	)	$	-	$	-	$	(77,893,482	)

Note 11 - Stockholders' Equity

6 Months Ended

Jun. 30, 2026

Equity [Text Block]

NOTE 11 – STOCKHOLDERS’ EQUITY

At The Market Offering

On May 3, 2024, the Company entered into an at-the-market (“ATM”) sales agreement with Wainwright & Co., LLC (“Wainwright”), under which it may issue and sell shares of its common stock, with Wainwright acting as sales agent and receiving a 3.0% commission on gross proceeds. The Company subsequently filed a shelf registration statement and prospectus supplement.

On April 18, 2025, in accordance with the terms of the Sales Agreement, the Company filed a prospectus supplement to the May 2024 Shelf Registration Statement relating to the offer and sale of up to an additional $1.5 million of shares of the Company’s common stock.

On June 2, 2025, in accordance with the terms of the Sales Agreement, the Company determined to further increase the number of shares it may sell under the Sales Agreement, from the approximately $1.4 million remaining as of May 31, 2025, up to an aggregate of $3.4 million, and the Company filed an additional prospectus supplement with the SEC on June 2, 2025.

On October 29, 2025, in accordance with the terms of the Sales Agreement, the Company determined to further increase the number of shares it may sell under the Sales Agreement, from the approximately $2.3 million remaining as of September 30, 2025, up to an aggregate of $18.3 million, and the Company filed an additional prospectus supplement with the SEC on October 29, 2025.

During April 2026, the company sold 1,063,864 shares of common stock pursuant to the Sales Agreement at an average price of approximately $10.22 per share, resulting in approximately $10.3 million in aggregate net proceeds, after deducting commissions and offering costs.

On May 15, 2026, in accordance with the terms of the Sales Agreement, the Company filed an additional prospectus supplement with the SEC increasing the aggregate amount of common stock that may be offered and sold under the Sales Agreement to up to $100 million, inclusive of approximately $17.0 million of shares previously sold under the Sales Agreement, resulting in approximately $83.0 million remaining available to the Company for future sales thereunder. Since the Company's public float exceeded $75.0 million as of May 15, 2026, the Company is no longer subject to the baby shelf limitations of General Instruction I.B.6 of Form S-3.

As of June 30, 2026, approximately $83.0 million remained available to the Company for sales under the Sales Agreement.

September 2025 Private Placements and Related Agreements

On September 29, 2025, the Company entered into a securities purchase agreement (the “Crypto SPA”) with certain accredited investors pursuant to which the Company agreed to sell and issue to such investors in a private placement (the “Crypto PIPE Offering”) pre-funded warrants (the “Crypto PIPE Warrants”). Also on September 29, 2025, the Company entered into a securities purchase agreement (the “Cash SPA,” and together with the Crypto SPA, the “September SPAs”), pursuant to which it agreed to sell and issue to certain accredited investors, in exchange for cash (the “Cash PIPE Offering,” and together with the Crypto PIPE Offering, the “PIPE Offerings”), the Company’s common stock and warrants (the “Cash PIPE Warrants”). The PIPE Offerings closed October 7, 2025 (the “Closing Date”).

Cash PIPE and Crypto PIPE

In the Cash PIPE Offering, the Company sold an aggregate of 4,366,703 shares of common stock (or pre-funded warrants at a nominal $0.01 exercise price per share to purchase shares of common stock, in lieu thereof) to certain accredited investors for $11.6265 per share. In the Crypto PIPE, the Company issued, to certain accredited investors, Crypto PIPE Warrants to purchase up to 14,903,393 shares of its common stock at a nominal $0.01 exercise price per share.

There were 6,146,671 pre-funded warrants exercised for the six months ended June 30, 2026, and the total number of pre-funded warrants outstanding was 9,972,424 as of June 30, 2026, all of which were vested and exercisable and have no expiration date.

Stock Warrants

The following summarizes transactions for warrants for the period indicated:

	Number of Shares			Weighted-Average Exercise Price
Outstanding as of December 31, 2025		1,623,179		$	17.39
Issued		-
Expired		-
Exercised		(6,136	)		219.09
Outstanding as of June 30, 2026		1,617,043		$	16.62

There were no warrants granted for the six months ended June 30, 2026 and 2025, respectively.

The entire disclosure for equity.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 20
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479951/505-20-S50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 20
-Name Accounting Standards Codification
-Section S25
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479982/505-20-S25-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S45
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 20
-Name Accounting Standards Codification
-Section S50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479951/505-20-S50-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 20
-Name Accounting Standards Codification
-Section S25
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479982/505-20-S25-2

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.C)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481520/505-30-50-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 20
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 1.D.2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479921/505-20-S99-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 20
-Name Accounting Standards Codification
-Section S50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479951/505-20-S50-3

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 855
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 1.B.3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480148/855-10-S99-1

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 20
-Name Accounting Standards Codification
-Section S25
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479982/505-20-S25-3

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/505/tableOfContent

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-5

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 505
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478448/946-505-50-6

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-6

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 16
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-16